Prolonged survival by 'early' salvage treatment of breast cancer patients: a retrospective 6-year study
1997

Early Treatment for Breast Cancer Patients

Sample size: 384 publication Evidence: moderate

Author Information

Author(s): A Nicolini, L Anselmi, C Michelassi, A Carpi

Primary Institution: University of Pisa, Italy

Hypothesis

Can early salvage treatment based on rising tumor markers improve survival in breast cancer patients?

Conclusion

Early salvage treatment based on tumor marker increases can significantly prolong survival in breast cancer patients compared to conventional treatment.

Supporting Evidence

  • Patients treated early had a median survival of 60 months from mastectomy compared to 44.5 months for those treated later.
  • 42.9% of patients treated early survived 72 months after mastectomy, compared to 22.7% of those treated later.
  • The lead time from tumor marker increase to clinical signs was significantly longer in early treated patients.

Takeaway

If doctors treat breast cancer patients early when their tumor markers go up, they can live longer than if they wait for other signs of cancer.

Methodology

Patients were followed post-operatively and treated based on tumor marker increases, comparing outcomes between early and conventional treatment groups.

Potential Biases

Potential bias due to the non-randomized nature of the study.

Limitations

The study is retrospective and may be affected by lead time bias.

Participant Demographics

384 breast cancer patients, with a mean age of 53 years, including both pre- and post-menopausal women.

Statistical Information

P-Value

P < 0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication